FIND DOCTORS
-
Name: Meng,Zhiqiang
Department: TADITIAON CHINESE MEDICINE/INTEGRATIVE ONCOLOGY
Title:ProfessorEducation & Professional Experience 2005-Present Deputy Chief, Dept. of Integrative Oncology, Fudan University Cancer Hospital
2003-Present Associate Professor, Dept. of Integrative Oncology, Fudan University Cancer Hospital
1999-2002 Assistant Professor, Dept. of Integrative Oncology, Fudan University Cancer Hospital
1996-1999 Attending physician, Dept. of Integrative Oncology , Fudan University Cancer Hospital
Research Completed Research Support
U19 CA12150301 Cohen (PI) 09/30/05 - 09/31/09
National Cancer Institute
International Center of TCM for Cancer
The proposed study will involved three collaborative research programs: 1) Evaluating herbal/nature product treatments that target disease outcomes and treatment– and disease-related symptoms. 2) Determine the effects of acupuncture on specific clinical symptoms in patients with cancer. 3) Examine the biobehavioral effects of qigong and other mind-body-based interventions in patient with cancer.
Role: Co-Investigator
06DZ19747
Shanghai Nature Science Foundation 10/01/06 – 09/30/09
Investigation of a new herb medicine that in liver cancer treatment.
The purpose of this study is to investigate a new herb medicine that use in liver cancer treatment. Include the formula, quality control and mechanism.
Role: PI
1 R21 CA108084-01 Cohen (PI) 09/30/03 – 08/31/05
National Cancer Institute
International Center of TCM for Cancer
The proposed study will involved three collaborative research programs: 1) Evaluating herbal/nature product treatments that target disease outcomes and treatment– and disease-related symptoms. 2) Determine the effects of acupuncture on specific clinical symptoms in patients with cancer. 3) Examine the biobehavioral effects of qigong and other mind-body-based interventions in patient with cancer.
Role: Co-Investigator
05DZ19701 10/01/05 – 09/30/08
Shanghai Nature Science Foundation
Acupuncture for the Prevention of Radiation-Induced Xerostomia.
This study is investigate if acupuncture is effective in preventing xerostomia among cancer patients at Fudan University Cancer Hospital (Cancer Hospital) who receive radiation treatment to the head and neck area. Determine whether acupuncture reduces the severity of xerostomia. And determine the feasibility of providing acupuncture treatment to patients at Cancer Hospital who are receiving radiation treatment for cancer of the head and/or neck area.
Role: PI
00JG05048 01/01/01－01/30/03
Shanghai Municipal Education Commission
The inhibition of telomerase and c-myc by JianPiLiQi herb formula in liver cancer cell.
The outcome of this study shows JianPiLiQi herb formula inhibited the growth of liver cancer cell in vitro. The proposal mechanism may cause by down regulation of telomerase and c-myc gene.
Role: PI
JG0003 09/01/00－02/28/03
Shanghai Bureau of Health
Clinical research of combination with chemotherapy and Chinese medicine in colon cancer treatment.
The aim of this study is to investigate the function of Chinese herb medicine in colon cancer integrative treatment. The result showed the patients received chemotherapy combined Chinese herb improve the response rate and helpful to quality of life.
Role: PIPublication 1. Meng ZQ. Photodynamic therapy in cancer treatment. Foreign Medical Sciences,24:345-347,1997.
2. Meng ZQ, Yu EX. Good pain management and TCM therapy. Chin J Oncol,25:408-409,2003.
3.Meng ZQ, Yu EX, Song MZ. Inhibition of telomerase activity of human liver cancer cell SMMC-7721 by chemotherapeutic drugs. World Chinese Journal of Digestology,7:252-254,1999.
4. Meng ZQ, Yu EX, Song MZ, Huang WX. Inhibition of telomerase activity by JianPiLiQi formula in liver cancer. Chinese Journal of Basic Medicine in Traditional Chinese Medicine,6:23-26,2000.
5. Meng ZQ, Guo WJ, Yu EX, Song MZ, Huang WX. Inhibition of telomerase activity and induced apoptosis of liver cancer cell SMMC-7721 by drug serum of Jianpi LiQi herbs. World Chinese Journal of Digestology,8:879882,2000.
6. Meng ZQ, Song MZ, Huang WX, Yu EX. The effects of different drugs on telomerase activity of liver cancer cell. Chinese Journal of Cancer ,19:317-320,2000
7. Meng ZQ, Xu YY, Liu LM, Song MZ, Huang WX. Clinical evaluation of integration of transcatheter arterial chemoembolization and traditional Chinese medicine in treating metastatic liver cancer. Journal of Chinese Integrative Medicine ,1:187188,2003.
8. Meng ZQ, Wu HM, Chen Z, Huang WX, Song MX. The inhibition of telomerase activity and c-myc expression in SMMC-7721 liver cancer cell by interferon α-2b. Shanghai Medical Journal,24:137-139,2001.
9. Meng ZQ, Huang WX, Wang ZJ. Phase II clinical trial of uroacitides in breast cancer. Bulletin of Chinese Cancer, 11:113-114,2002
10. Zhu RF, Yu SZ, Zhang JD, Wang SZ, Dong Y, Zhu YY, Meng ZQ, Jia QS. The plasma level detection of TXB2、6-K-PGF1α、t-PA、PAI in stroke patient. Journal of Shandong University of Traditional Chinese Medicine,21:39-41,1997.
11. Wu HM, Meng ZQ. Use Chinese herb to treat the UC. Journal of Shandong University of Traditional Chinese Medicine,21:128-129,1997.
12. Wu HM, Meng ZQ. The correlation between plasma D-dimer and pathologic index of TCM in stroke patines. Liaoning Journal of Traditional Chinese Medicine ,25:151-152,1998.
13. Xia YY, Li J, Meng ZQ. The effect of ovarian function in cancer patients undergo chemotherapy. Chinese Journal of Clinical Oncology and Rehabilitation,5:20,1998.
14. Meng ZQ. The ileus after TACE in liver cancer patient: 1 case report. China Oncology,1:11,1999.
15.Cheng WW, Lin JH, Li GA, Xu YY, Cheng L, Meng ZQ, Chen Z, Zhou ZH, Song MZ, Sun L, Chen H. The treatment effect of Navoban in liver cancer TACE. Chinese Journal of Clinical Oncology,28:787-788,2001.
16. Guo WJ, Meng ZQ, Qian GZ, Shen ZZ, Luo JM, Zheng SG, Sun YX, Hu L. Study on the inhibition of drug resistant human breast cancer cells with hexogenous tumor necrosis factor-α gene therapy. Chinese Journal of Experimental Surgery,19:31-33,2002.
17. Lin JH, Li GA, Zhou ZH, Chen H, Cheng L, Chen Z, Meng ZQ. The clinical study of Oxaliplatin in metastatic liver cancer TAC treatment. Journal of Practical Oncology, 17:337-338,2002.
18. Li XP, Huang WX, Chen Z, Meng ZQ, Liu LM. Impact of hyperglycemia on the effect and prognosis in hepatocellular carcinoma. Journal of Oncology,9:85-87,2003.
19. Zhou QH, Hou H, Li L, Ren L, Qiu Y, Yang YQ, Huang WX, Chen Z, Meng ZQ, Song MZ, Li MZ, Li EX, Li Y, Yao L, Zheng ZW, Liu X, Zhang XF, Lu HS, Zhang MH, Wang XW, Yu XJ. A multi-center randomized phase II trial of domestic product of nrh-TNF in the treatment of non-small cell lung cancer. Chinese Journal of Lung Cancer,6:42-45,2004
20. Zhou QH, Yan X, Ren L, Li L, Qiu Y, Yang YQ, Luo DY, Huang WX, Liu LM, Chen Z, Meng ZQ, Wang YJ, Fu Q, Xu Y, Yang LJ, Li MZ, Li EX, Li Y, Yao L, Zhang XF, Liu X, Lu HS, Zhang MH, Wang XH, Yu XJ, Qin FZ, Zheng RS, Chen YQ, Bi MH. Chinese Journal of Lung Cancer,6:264-267,2003.
21. Li XP, Huang WX, Chen Z, Meng ZQ, Liu LM. Abnormal of glycemia on the effect and prognosis in primary liver cancer. Journal of Practical Oncology,18:217-219,2003.
22. Li XP, Chen Z, Meng ZQ, Huang WX, Liu LM. Integrative treatment of kidney cancer with liver metastasis. 7 cases report. Chinese Archives of Traditional Chinese Medicine,21:1930-1931,2003.
23. Chen Z, Liu LM, Huang WX, Song MZ, Meng ZQ, Qian Hao. A clinical research on rnh-TNF for 87 cases with advanced cancer. Chinese Journal of Clinical Oncology,30:877-880,2003
24. Li XP, Chen Z, Meng ZQ, Huang WX, Liu LM. Study on the treatment of liver metastasis from breast cancer. Tumor 24:73-75,2004
25. Li XP, Chen Z, Meng ZQ, Huang WX, Liu LM. Study on the treatment of liver metastasis from esophageal cancer. China Journal of Cancer Prevention and Treatment,11:524-526,2004
26. Li XP, Chen Z, Meng ZQ, Huang WX, Liu LM. Concurrent hyperlycemia does not influence the long-term prognosis of unresectable hepatocellular carcinomas. World J Gastroenterol,9:1848-1852,2003
27. Guo WJ, Yu EX, Liu LM, Chen Z, Lin JH, Meng ZQ, Feng Y. Comparison between chemoemboliaztion combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma. World J Gastroenterol,9:1697-1701,2003
28. Wang P, Meng ZQ, Chen Z, Lin JH, Zhou ZH, Chen H, Wang K, Shen YH, Zhu ZF, Zhao GF, Fu H, Liu LM. Survival rate of pancreatic cancer in elderly patients. Hepatogastroenterology 2008;55(82-83):681-686
29. Wang P, Meng ZQ, Chen Z, Lin JH, Ping B, Wang LF, Wang BH, Liu LM. Diagnostic value and complications of fine needle aspiration for primary liver cancer and its influence on the treatment outcome- a study based on 3011 patients in China. Eur J Surg Oncol. 2008;34(5):541-546
30. Zhou ZH, Liu LM, Chen WW, Meng ZQ, Lin JH, Chen Z, Zhang XJ, Jiang GL. Combined therapy of transcatheter aarterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinoma. Br J Radiol 2007,80(951):194-201Awards 1997 Orient Medical Bursary, Shanghai Medical University, Shanghai.
1998 Federal Medical Bursary, Shanghai Medial University, Shanghai.
2002 Best Medical Thesis, Chinese Association of Medicine in ShanghaiOut-patient Schedule Monday Morning
